Bridging the Gap: Drugs, Devices, and Biologics.
Introducing Drug-Eluting Biomaterials.
At Elutia we’re pioneering the future of patient care. Our proprietary drug-eluting biomaterial platforms stand at the forefront of medical innovation. We are dedicated to addressing the pressing challenges that can arise from medical device implant failures. By combatting post-surgical complications that impact patient outcomes and escalate medical costs, we’re ensuring patients not only recover, but thrive without compromise.
Bridging the Gap: Drugs, Devices, and Biologics Introducing Drug-Eluting Biomaterials.
At Elutia we’re pioneering the future of patient care. Our proprietary drug-eluting biomaterial platforms stand at the forefront of medical innovation. We are dedicated to addressing the pressing challenges that can arise from medical device implant failures. By combatting post-surgical complications that impact patient outcomes and escalate medical costs, we’re ensuring patients not only recover but thrive without compromise.
Our Mission
Humanizing medicine so patients can thrive without compromise.
“Our proprietary drug-eluting biomaterial technology ensures the full therapeutic benefit of medical implant devices and reconstruction procedures. Our goal is to eliminate the all-too-frequent challenge of post-surgical complications and ensure every patient can thrive without compromise.”
C. Randal Mills, PhD.
Founder, President, and CEO, Elutia
Thrive Without Compromise.
Next Generation Drug-Eluting Biomaterials.
Elutia offers a proprietary drug-eluting biologic technology: a fusion of natural biologic material and extended antibiotic release, perfected for device implantation and soft tissue reconstruction. Our offerings, CanGaroo for implantable electronic devices and SimpliDerm for soft-tissue reconstruction, provide robust, but easy-to-use constructs that ensure implant stability and promote wound healing. Notably, both products mitigate fibrotic responses that can lead to poor outcomes.1
Electrophysiology
CanGaroo
Acellular device envelope for placement of pacemakers, defibrillators, and neurostimulators to optimize stability and support healthy wound healing.
Neuromodulation
CanGaroo
Acellular envelope to mitigate device migration and erosion by securing the device and supporting healthy wound healing.
Plastic Surgery
SimpliDerm
Human acellular dermal matrix for repair and replacement in soft tissue reconstruction.
Elutia Digital Education
Want to Receive Updates About Upcoming Webinars?
Join us for our free digital education series. Click the button below and sign up today for access to our next webinar.
1. Data on file at Elutia Inc.
WMK-1502-01C
